• Home
  • About Us
    • Company Profile
    • Company History
    • Company Honor
      • Other
      • Company Honor
      • Patent Authorization
      • ISO 9001 Certification
  • Products
    • TDM (Therapeutic Drug Monitoring)
    • IVD Products
    • CLIA
    • FICA(POCT)
    • Rapid Test
    • Clinical chemistry
    • Raw materials
    • Nucleic Acid Synthesis Service
    • RNA CRO Service
    • OEM & Uncut Sheet
    • Quality control products
    • Instrument
  • News
    • Company News
    • Industry News
  • Service
    • Pre Sales Service
    • Download Center
  • Recruit
    • Talent Recruitment
    • People in DIAGREAT
      • 团队活动
  • Contact Us

CN

|

EN

  • Company News
  • Industry News
Current Location:HomeNewsCompany News
10-31
2025
Why is vancomycin blood concentration monitoring necessary Vancomycin is a widely used glycopeptide antibacterial agent in clinical practice. It is primarily employed as a first-line therapy for Gram-positive coccus infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA). However, vancomycin has a narrow therapeutic window and significant pharmacokinetic variability among individuals. Its efficacy is eas
Why is vancomycin blood concentration monitoring necessaryVancomycin is a widely...
Learn more
  Why is vancomycin blood concentration monitoring necessary      Vancomycin is a widely used glycopeptide antibacterial agent in clinical practice. It is primarily employed as a first-line therapy for Gram-positive coccus infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA). However, vancomycin has a narrow therapeutic window and significant pharmacokinetic variability among individuals. Its efficacy is eas
09-29
2025
Grand Finale | DIAGREAT Shines at 2025 Guangzhou CMEF
Learn more
Grand Finale | DIAGREAT Shines at 2025 Guangzhou CMEF
09-17
2025
【INVITATION】IATDMCT 2025 in Singapore
The 23rd International Congress on Therapeutic Drug Monitoring and Clinical Toxi...
Learn more
【INVITATION】IATDMCT 2025 in Singapore
08-29
2025
TDM ensures safety of drug combinations in organ transplantation
Invasive fungal infections (IFIs) are the leading cause of death in recipients o...
Learn more
TDM ensures safety of drug combinations in organ transplantation
  • All36page
  • One page
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • Next
  • Last page
Service Hotline
010-69502385

Address:Building 19, yard 2, huanke Middle Road, Tongzhou District, Beijing

Mailbox:info@diagreat.com

      export@diagreat.com

    services@diagreat.com


  • About Us
    • Company Profile
    • Company History
    • Company Honor
  • Products
    • TDM (Therapeutic Drug Monitoring)
    • IVD Products
    • CLIA
    • FICA(POCT)
    • Rapid Test
    • Clinical chemistry
    • Raw materials
    • Nucleic Acid Synthesis Service
    • RNA CRO Service
    • OEM & Uncut Sheet
    • Quality control products
    • Instrument
  • News
    • Company News
    • Industry News
  • Service
    • Pre Sales Service
    • Download Center
  • Recruit
    • Talent Recruitment
    • People in DIAGREAT
  • Contact Us

Official Wechat

Copyright @ 2019 - 2020 Beijing DIAGREAT Biotechnology Co., Ltd All Rights Reserved
犀牛云提供企业云服务
Website Map
京ICP备18058493号-1
京公网安备 11030102011547号
  • E-mail inquiries

    info@diagreat.com
  • whatsapp

E-mail inquirieswhatsapp
Click on the phone to make a call
  • info@diagreat.com

Please select customer service to chat

  • whatsapp